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 The technique of peripheral neural blockade was developed early 
in the history of anaesthesia. These techniques have evolved because of 
strong enthusiasm, and as the sole technique for surgeries and also as 
supplementary analgesia and for post operative pain management. 
 
 Anaesthesiologists are very skilled in performing variety of nerve 
blocks. Today because of advances in science and technology these 
techniques are made with more accuracy and reliability. 
 
 These techniques also evolved as other modes of anaesthesia can’t 
be given. These techniques avoid the complications of general 
anaesthesia and also where general anaesthesia is not advisable. 
 
 The peripheral nerve blockade provides better haemodynamic 
conditions and also provides good post-operative pain relief. Few surgical 
procedures below the knee can be done with sciatic nerve block alone. 
But when the sciatic nerve block is combined with femoral nerve block 
the entire lower extremity can be blocked providing surgical anesthesia 
and good post operative pain relief. Both nerve blocks are usually 
required because most surgeons use tourniquet which can cause 
significant discomfort and pain. Several techniques are known to block 
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sciatic nerve. But in my study anterior approach was used in which the 
block was done in supine position without moving the patient by using 
peripheral nerve stimulator. 
 
PERIPHERAL NERVE STIMULATORS: 
 
         Until recently, elicitation of parasthesia has been a classical method 
to locate nerves for peripheral nerve blocks.Peripheral nerve stimulator 
technology utilizes objective end points for nerve localization and does 
not depend on patient’s cooperation for effective nerve localization. An 
effective use of PNS technology mandates the knowledge of anatomy 
with respect to  
 
¾ Optimal needle insertion site to achieve needle tip-target nerve 
contact 
¾ Muscle innervations scheme of the targeted nerve to identify 
desired evoked motor response (EMR) 
¾ Ability to differentiate desired EMR from the alternate EMR”s 
elicited by the stimulation of adjacent muscles and collateral nerves 
¾ And, the relationships of the adjacent neuromuscular structures 
generating these alternate EMR”s to the targeted nerve. 
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Therefore an algorithm can be designed for needle redirection 
during PNS assisted PNB. 
 
This study attempts to evaluate the technique of combined sciatic 
and femoral nerve block through anterior approach by using the 










AIM OF THE STUDY 
 
 
 To evaluate the technique and success of combined sciatic and 
femoral nerve block through anterior approach via single point of entry 
















1. “The doctrine of specific energies of the senses” – proclaimed by 
Johannes P.Mueller in 1826 stated that “it is the nerve that 
determine what the mind previous which opened up a new field of 
scientific thought and research into nerve function”. 
 
2. Theory by Moritz.S. Schiff in 1858 claimed pain as a separate and 
distinct sense.   
 
3. In 1845 on 3rd June Sir France Rynd appointed surgeon to meath 
hospital delivered morphine solution to a nerve for relieving 
intractable neuralgia – solution delivered by means of gravity 
through cannula. 
 
4. First use of syringe and hypodermic needle in 1855 by Alexander 
wood. 
5. Carl Koller, an intern at ophthalmologic clinic at university of 
Vienna gave topical anaesthesia with cocaine on September 11, 
1884 for glaucoma correction. 
 
6. 1884 William Steward Halsted performed first documented 
Brachial plexus anaesthetic under direct vision of John Hopkins. 
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7. In 1911 Hirschel and Kulenkompff performed first percutaneous 
Axillary and supraclavicular Brachial plexus blocks. 
8. Victor pauchet in 1914 published the textbook for Regional 
anaesthesia – ‘L’ Anesthesie regionale” the first book of its kind. 
9. Gaston Labat in 1922 published the first edition of “Regional 
anaesthesia – technique and clinical applications”. 
 
10. In 1923 an American society of regional anaesthesia was found. 
 
11. Continuous peripheral nerve block with catheters was first 
performed in 1946. Anghoro did the first continuous brachial 
plexus block in 1946. 
 
12. In 1973 Montgomery Raj first used nerve stimulator in clinical 
practice. 
13. Rosenblatt was the first to use catheters to provide continuous 





ANATOMY OF   LUMBAR PLEXUS 
Lumbar plexus lies deep in the psoas major muscle in front of the 
transverse process of lumbar vertebrae.        
         
It is formed by  - ventral rami of first four lumbar nerve 
   - greater part of ventral rami of fourth lumbar nerve 
 
 All the branches of plexus emerge from the substance of psoas 
major muscle. 
 
 L1 –frequently supplemented by T12 divides into upper and lower 
branches. 
 
 Upper branch gives illioinguinal and illiohypogastric nerves. 
 Lower branch  unites with L2 to form genitofemoral nerve.      
 L2, L3, L4 - divides into ventral and dorsal division. 
                      -Ventral division as obturator nerve 
                      -Dorsal division as femoral nerve and 





Relations of Lumbar plexus and its branches: 
 Lumbar plexus forms within (or) passes through the space between 
quadratus lumboram and psoas major muscle. At this point the nerve lies 
within the compartment formed by the fascia of these muscles. 
 
Branches: 
 Lateral cutaneous nerve of thigh -leaves medial border of psoas 
major at its midpoint to enter lateral thigh at a very superficial level. 
 
 Obturator nerve – leaves medial border of psoas major and enter 
medial thigh at a very deep level. 
 
 Femoral nerve the largest branch of plexus appears at the lateral 
margin of psoas major muscle and remains in the groove between psoas 
major and iliacus muscle. At the base of femoral triangle the nerve lies 
one finger breadth lateral to the femoral artery. In the femoral triangle the 
nerve divides into anterior and posterior division.  
 
Anterior division gives muscular branches to 
1) Pectinius       
2) Sartorius  
    cutaneous branches  
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3) Intermediate cutaneous nerve of thigh 
4) Medial cutaneous nerve of thigh 
 
Posterior division: 
 Muscular branches to quadriceps femoris  
 Cutaneous branch – saphenous nerve 
 
 The saphenous nerve is the largest cutaneous branch of the femoral 
nerve and the only cutaneous branch to originate from the posterior 
division. This nerve gives sensory innervation to the medial aspect of the 
knee, leg, ankle and foot. 
                                        
Femoral Nerve Block:                                
 It is relatively easy to block the femoral nerve just inferior to the 
inguinal ligament. A needle passed just lateral 1-2 cm to femoral artery 
with cephalad angulation. If a nerve stimulator is used contractions of the 
quadriceps femoris will cause the patella to dance which is considered as 
the evoked motor response of femoral nerve. 
 
 Since the saphenous nerve originates from the posterior division of 
the femoral nerve, the end point of locating the nerve is confirmed when 
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patellar dance is considered as the evoked motor response, since both  the 
branches originate from the posterior division. 15ml of the local 
anaesthetic mixture is infiltrated to block the femoral nerve. 
 
Sacral Plexus:  
 It is formed by anterior primary rami of L4, L5, S1, S2, and S3. The 
L4, L5 fuse to form lumbosacral at the medial border of psoas muscle and 
passes over the pelvic brim and join S1 at the sacroiliac joint. The anterior 
primary rami of S1-S4 emerge through anterior sacral foramina; S5 
appears between the inferior lateral angle of the sacrum and the 
transverse process of the coccyx and escapes below the transverse 
process, piercing the coccygeal muscle.       
 
The branches of sacral plexus: 
a) Collateral  1) Muscular 
   2) Cutaneous 
   3) Visceral 
b) Terminal   1) Sciatic  





Sciatic Nerve (L4, 5 S1-3) 
 It is the largest peripheral nerve in the body. It is flattened at its 
origin. It is made up of two nerve components, tibial and peroneal, within 
one common sheath of fibrous tissue. This nerve usually splits into two 
components at the apex of the popliteal fossa, but the division may occur 
proximally also. Occasionally the two components are separate from its 
origin itself. But it is rare. 
 
Relation: 
 Sciatic nerve leaves the posterior pelvic wall through greater sciatic 
foramen below pyriformis and descends midway between the ischial 
tuberosity and greater trochanter. The sciatic nerve then descends 
vertically down the midline as far as to the apex of popliteal fossa. 
 
Surface marking: 
The sciatic nerve can be marked by a line which connects the 
posterior superior iliac spine and tip of the ischial tuberosity, curves, 
outwards and downwards just medial to the mid point joining greater 
trochanter and ischial tuberosity and then continues vertically downwards 
in the posterior aspect of thigh. 
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Sciatic nerve block 
 It can be blocked by 
1) Labat – the posterior approach 
2) Anterior approach 
3) Lateral approach 
4) Raj approach 
 
Anterior Approach of Sciatic Nerve Block: 
Land Marks: 
  The anterior approach to the sciatic nerve was delovoped to over- 
come the problem of patient positioning. The land marks are the inguinal 
ligament and the greater trochanter of femur. First a line joining the 
anterior superior iliac spine and pubic tubercle is drawn. This represents 
the inguinal ligament. Another line joining the greater trochanter is drawn 
parallel to the first line. From the first line at the junction of lateral 2/3rd 
and medial 1/3rd a perpendicular line joins which intersects at the 2nd line. 




 With the help of the nerve stimulator the end point for locating the 
nerve is dorsi (or) plantar flexion of the foot which is considered as the 
evoked motor response with 0.4ma as the lower limit of current used. 
 
 The other methods of sciatic block can be done by eliciting 
parasthesia.  
 By performing both sciatic and femoral block the sensory 
distribution completely below the knee is completely blocked and any 
type of surgery can be done below the knee. 
 
Peripheral nerve stimulator 
  The use of peripheral nerve stimulators in regional anaesthesia is 
not new. As early as 1912, Von Perthes described the use of peripheral 
nerve stimulators. With the resurgence of interest in regional anaesthesia 
and demand for more accurate nerve localization before injection of 
Local anaesthetics it comes as a no surprise that often Nerve stimulators 
be used. In 1850 von Helmohlz had Showed an isolated nerve muscle 
Preparation, and the Temporal nature of nerve fiber conduction and 
elucidation of the relevant physiology of peripheral nerve stimulation. Of 
particular importance is the relationship between the Strength and the 
duration of the current and the polarity of the stimulus. In order to 
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propagate a nerve impulse, a Certain threshold stimulus must be applied 
to the nerve.  
Of note, below this threshold, no impulse is propagated, and 
increase in the intensity of the stimulus above this threshold propagation 
or triggered impulse is further increased. Assuming a square pulse of the 
current is used to stimulate the nerve, the total energy applied to the nerve 
is a product of the intensity of the current and the duration of the of the 
pulse. There are two terms important to understanding the nerve 
stimulation: the reobase and chronaxie. The reobase is the minimal 
current required to the nerve with a long pulse. The Chronaxie is the 
duration of the stimulus required to Stimulate at twice the reobase.The 
chronaxie can be used as a measure of the threshold for any particular 
nerve and it is useful when comparing different nerves or nerve fibre 
types. 
A nerve stimulator supplies electrons to depolarise a nerve. The 
number of electrons supplied per stimulus equals the current. 
 
Placement of electrodes 
An important principle of peripheral nerve stimulation is the 
preferential cathode stimulation. For instance, when the nerve is 
stimulated by an electrode, significantly less current is needed to obtained 
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a response to nerve stimulation when the cathode (negative) is adjacent to 
the nerve, rather than the anode (positive is adjacent to the nerve). The 
reason for this phenomenon is because when the stimulating electrode is 
negative, the current flow alters the resting membrane potential adjacent 
to the needle, producing an area of depolarization which then spreads 
across the nerve. When the electrode adjacent to the nerve is an anode, 
the current causes an hyperpolarization adjacent to the needle and a ring 
of depolarization distal to the needle tip. This arrangement is less efficient 
in propagating the stimulus and has clinical Implications. 
 
Types of Nerve Stimulator: 
The connection between the electrodes and the skin is not constant. 
If the electrodes dry out or come a bit loose from the skin their resistance 
will increase. There are two ways a nerve stimulator can respond to this 
change...with a constant voltage or a constant current.  
Voltage = Current X Resistance 
 
Constant Voltage Nerve Stimulators 
Constant voltage nerve stimulators are relatively easy and cheap to 
make. Unfortunately if the voltage remains constant when resistance 
increases then the current must decrease. As a result the nerve may not be 
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completely stimulated. The muscle contraction will then be depressed. 
The anaesthetist will falsely think that the neuromuscular blocking drug is 
still working. This can be dangerous if the patient moves during a delicate 
phase of surgery. 
 
Some constant voltage nerve stimulators will display the current 
actually delivered and will alarm if it falls below some predefined 
threshold. 
 
Constant Current Nerve Stimulators 
Constant current nerve stimulators are the safest but also the most 
expensive to build. As the resistance of the electrodes goes up they 
compensate by increasing their voltage. As a result the current stays 
constant. The stimulation of the nerve remains constant. Any change in 
response is occurring at the neuromuscular junction or in the muscle 
itself. 
 
There is a limit to how high the nerve stimulator can raise the 
Voltage. At this point the stimulator should give an audible and Visual 
alarm that the stimulating current has not been reached. 
 
 23
The nerve stimulator offers feature enhancements such as: 
Selectable stimulus pulse duration: 0.1ms, 0.3ms, or 1.0ms. 
Switchable linear current range – from 0-1 mA or from 0-5 mA - 
enabling increased accuracy when stimulating at low current levels .Two 
different display modes: desired current setting, or actual current delivery 
to patient.  
Ability to vary the pulse duration allows the localization of 
practically all mixed nerves for plexus and peripheral nerve blocks. 
 
0.1ms = Motor Nerve Response Short, rectangular pulse width 
duration of 0.1ms targets A alpha large nerve fibres to generate pain free 
motor responses in the patient. 
 
0.3ms = Motor + Sensory Nerve Response Selecting a pulse 
duration of 0.3ms may enable selective stimulation of motor fibres with 
minimal unpleasant sensations for the patient. Blockade performance 
time may also be shortened by use of longer pulse duration of 0.3ms 
1.0ms = Sensory Nerve Response In addition, pure sensory nerves 
can be located using a longer pulse duration of 1.0 ms to stimulate 
sensory fibres. 
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The special insulation coating of the D Series needles exposes only 
the pin point tip of the needle. This concentrates the entire stimulus 
current at the extreme needle tip.  
Enables to precise nerve localization at the lowest threshold 
currents. 
The D Series needles will be available in a variety of procedural 
lengths to suit practically all indications in plexus anaesthesia. You also 
have your choice of 15° or 30° bevels according to your personal 
preference of puncture force and gliding characteristics 
 
Characteristics of an ideal PNS: 
1. Constant current output-A particular current not the voltage 
stimulates the nerve. Therefore, the current delivered by the device 
should not vary with changes in the resistance of the external 
circuits.  
2. Digital display of the delivered current 
3. Variable output control 
4. Clearly identifiable polarity 
5. Option for different pulses 
6. A wide range of current output 0.1-5.0mA 
7. Battery indicator  
 25
Peripheral nerve stimulator settings: 
 MIXED NERVE (most PNB) 
 Current (dial) -> 1mA 
 Current duration-0.1ms 
 Frequency-> 1-2Hz 
 SENSORY NERVE (eg-Lateral femoral cutaneous and saphenous 
nerves) 
 Current (dial)->2-5mA 
 Current duration-1ms 
Frequency-1Hz 
 
DIABETIC NEUROPATHY (PNB) 
Current (dial)->2mA 
Current duration->0.3ms 










 Bupivacaine is an amide linked local anaesthetic. It is a 
hydrochloride salt of d (1)-1-butyl 2’6’ pipecoloxylidide and is presented 
as a racemic mixture. 
¾ It was synthesized by EO af Ekenstem. 
¾ First reports of its use were published in 1963 by Telivuo. 
¾ It is derived from Mepivacaine and is very stable compound and 
may be autoclaved repeatedly. 
Pka is 8.1 
MW - 288  
Protein binding  - 95% 
Lipid solubility - 28 
Elimination half life - 210mts 
Toxic plasma concentration - >1.5μg/ml 
Approximate duration of action  - 175mts 
 
Availability: 
 Ampoule - 0.5% Bupivacaine hydrochloride 4cc 
- 0.5% Bupivacaine hydrochloride with dextrose  
(heavy) 4cc 
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 Vials  - 0.25% and 0.5% Bupivacaine hydrochloride 20cc 
 Dosage - Maximum dosage 3mg/kg body weight. 
Uses: 
¾ Spinal anaesthesia 
¾ Epidural anaesthesia 
¾ Caudal anaesthesia 
¾ Continuous epidural anaesthesia 
¾ Peripheral nerve block 
 
Pharmacokinetics: 
  It is rapidly absorbed from the site of injection, but the rate of 
absorption depends on the vascularity at the site and presence of 
vasoconstrictors. 
 
 High lipid solubility of bupivacaine makes it easy for nerve and 
vascular tissue penetration. 
 
 80-95% of the absorbed bupivacaine binds to the plasma. 
 
Biotransformation: 
 Possible pathways of metabolism of bupivacaine include aromatic 
hydroxylation and conjugation. Only the N-dealkylated metabolite, N-
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desbutyl bupivacaine has been measured in blood (or) urine after epidural 
(or) spinal anaesthesia. Alpha1 acid glycoprotein is the most important 
plasma protein binding site of bupivacaine and its concentration is 
increased by many clinical situations including post operative trauma. 
 
Excretion: 
 It is through the kidney; 4-10% of the drug is excreted unchanged. 
 
Mode of Action: 
a) Sodium Channel blockade: 
 They impede sodium ion access to the axon interior by occluding 
the transmembrane sodium channels thus delaying the process of 
depolarization and axon remains polarized. It is a non-depolarization 
blockade.     
 
Pharmacodynamics: 
 It has got a longer duration of action but a slower onset. 
 
Toxicity: 
 Toxicity is related to plasma level of unbound drug and more likely 
due to an inadvertent intravenous injection. Systemic toxicity reactions 
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primarily involve central nervous system and cardio vascular system. The 
blood level required to produce central nervous system toxicity is less 
than that required to produce circulatory collapse.  
 
Central Nervous System Toxicity:    
 Initial symptom includes feeling of light headedness and dizziness, 
followed by visual and auditory disturbances. Objective signs are 
excitatory and include shivering, muscle twitching and tremor. Ultimately 
generalized tonic, clonic seizures occurs. 
 
Cardiovascular System Toxicity: 
 The rate of depolarization in fast conducting tissue of purkinje 
fibres and ventricular muscle is decreased. The rate of recovery of 
bupivacaine induced block is slower than that of lignocaine. Extremely 




PHARMACOLOGY OF LIGNOCAINE 
Lignocaine is a synthetic amide-linked anaesthetic of intermediate 
potency and duration.  In 1943 Lofgren synthesized Lignocaine in 
Sweden. First used by Gordh in 1948. 
Lignocaine is the standard to which all other local anaesthetics are 
compared.  It is currently the most widely used local anaesthetic.  In 
addition, it is a popular antiarrythmic.  It can be given by almost any 
route. 
Mechanism of action: 
 Lignocaine prevent transmission of nerve impulses by inhibiting 
passage of sodium ions through ion-selective sodium channels in the 
nerve membranes.  This slows the rate of depolarization such that the 
threshold potential is not reached and thus action potential is not 
propagated.  But resting membrane potential is not altered.  Lignocaine 
binds to the inner portion receptor (i.e. Sodium channel) after entering the 
cell membrane. 
Physiochemical properties: 
 Molecular weight 234 
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 Weak base with a pka 7.6 – 7.8 
 Very stable, not decomposed by boiling, acids or alkalis 
 It is less lipid soluble than that of Bupivacaine 
Pharmacokinetics: 
Absorption: 
 It is absorbed from the site of application or injection into the 
blood stream.  Rate of absorption depends on the blood flow to the area 
and use of epinephrine. 
 
Metabolism: 
 Metabolised in liver by oxidative dealkylation to monoethylglycine 
xylidide followed by hydrolysis of this metabolite to xylidide.  
Metabolism is dependant on hepatic blood flow. 
 Monoethylglycine xylidide has 80% activity of the parent drug. 
 Xylidide has 10% activity of the parent drug. 
 75% of xylidide is excreted in the urine as 4 – hydroxyl – 2, 6 –
dimethylaniline. 
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Onset of action: 
 Rapid onset of action 
 Topical anaesthesia  5-10 mins 
 Conduction anaesthesia 
   For small nerves 5-10 mins 
   For large nerves 10-15 mins 
 Intravenous administration 1-2 mins 
Protein binding: 
 It is 70% bound to α 1 acid glycoprotein 
Volume of distribution: 
 91 litres 
Distribution: 
 Lignocaine has a triphasic distribution 
Rapid distribution phase (α): 
 In this phase, the drug is distributed to highly vascular regions.  
t ½ α is 1 min. 
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Slow disappearance phase (β): 
 The drug is distributed to slowly equilibrating tissues. 
 t ½ β is 9.6 min. 
Slow transformation and excretion phase (δ): 
 t ½ is δ is 1.6 hrs 
 Clearance is 0.95 litres per minute 
Availability: 
a) 5% heavy 2 ml ampoules which contain 50 mg of lignocaine / 
ml with 75 mg – 100 mg of dextrose 
b) 2% ligcocaine (xylocard) without preservative – 50 ml vial for 
intravenous use 
c) 2% lignocaine – plain – 30 ml vial –contains methyl and propyl 
paraben as preservative 
d) 4% lignocaine with 1 in 200000 Adrenaline – 30 ml vial. 
e) 4% lignocaine viscus 
f) 4% lignocaine aqueous solution 
g) 10% lignocaine spray 
h) 2% lignocaine Jelly 
i) 2% lignocaine ointment  




 Causes nerve blockade with loss of pain and temperature sensation, 
touch, motor power and vasomotor tone in the region supplied by the 
nerves blocked. 
Systemic actions: 
 Result of systemic absorption from the site of administration or 
intravenous administration 
Cardiovascular system: 
 It has a stabilizing effect on the cell membranes of cardiac tissue. 
 Lignocaine depresses myocardial automaticity by antagonizing the 
spontaneous phase IV depolarization and reduces the duration of effective 
refractory period. 
 Myocardial contractility and conduction velocity are depressed at 
higher concentrations. 
 These effects result from direct cardiac muscle membrane changes 
(i.e.) cardiac sodium channel blockade. 
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 It stabilizes the membrane of damaged and excitable cells, tending 
to suppress ectopic foci. 
Respiratory system: 
 Lignocaine depresses hypoxic drive (the ventilatory response to 
low PaO2). 
 Apnea can result from phrenic and intercostal nerve paralysis or 
depression of the medullary respiratory center following direct exposure 
to the local anaesthetic agents. 
 Relaxes bronchial smooth muscle. 
 Intravenous lignocaine may be effective in blocking the reflex 
bronchoconstriction associated with intubation. 
Vascular smooth muscle: 
 Produces vasodilatation 
Central nervous system: 
 Produces a sequence of stimulation followed by depression. 
Produces sedation on intravenous administration. 
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 Intravenous administration decreases cerebral blood flow and 
attenuates the rise in intracranial pressure that accompanies intubation. 
 Infusion of lignocaine is capable of reducing the MAC of volatile 
anaesthetics by 40%. 
Musculoskeletal: 
 Lignocaine is myotoxic leading to lytic degeneration, edema and 
necrosis. 
Haematological: 
 It decreases coagulation and enhances fibrinolysis 
Indications: 
1. For infiltration block, peripheral nerve blocks, epidural, spinal 
and topical anaesthesia & intravenous regional anaesthesia. 
2. Antiarrythmic : 
Lignocaine is a class IB antiarrythmic. 
Ventricular tachyarrhythmias 
Arrhythmias following acute MI during cardiac surgery 
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  In digitalis toxicity – because it does not worsen AV – block 
3. Prevention or treatment of increases in intracranial pressure 
during intubation 
- antitussive effect may be the reason. 
4. Reflex induced bronchospasm is also attenuated by iv 
administration of lignocaine 
5. Suppresses noxious reflexes such as coughing & sympathetic 
stimulations associated with endotracheal suctioning and 
intubation. 
6. Used as an antiepileptic agent intravenously 
7. Used intravenously as an analgesic for certain chronic pain 
states 
8. Used as a supplement to general anaesthesia. 
Contraindications: 
 Hypersensitivity 
 Should not be used with vasoconstrictor in digits of hand, feet and 
penis 
 Stokes Adams syndrome, severe degree of heart block 
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Doses: 
Maximum recommended dose: 
 a) Plain  - 3 mg / kg 
 b) with adrenaline- 7 mg / kg 
 c) for reflex suppression - 1.5 mg / kg iv. 
Drug interactions: 
β Blockers: 
 Co administration of beta blockers, increases serum levels of 
lignocaine and its toxicity by decreasing lignocaine’s metabolism. 
Anticonvulsant agents: 
 Increases lignocaine’s metabolism 
Non depolarizing muscle relaxant: 
 Blockade is potentiated by lignocaine 
Opioids and  α 2 adrenergic agonists : 
 Potentiate lignocaine’s pain relief 
Antiarrythmic agents 




 Mostly due to systemic absorption of locally administered 
lignocaine or due to accidental intravenous administration of large doses 
of lignocaine. 
 The central nervous system is mostly vulnerable. 
Blood levels and symptoms : 
 4 µg / ml  :  Light headedness, tinnitus, circumoral and tongue 
numbness   ( anticonvulsant and antiarrhythmic activity) 
 6 µg / ml :  visual disturbances 
 8 µg / ml  :  muscular twitching 
 10 µg / ml :  convulsions 
 12 µg / ml  :  Unconsciousness 
 15 µg / ml   :  Coma 
 20 µg / ml   :  respiratory arrest 
 26 µg / ml   : cardiovascular collapse 
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Treatment of toxicity : 
 Continuous monitoring of CVS and RS status helps to identify the 
toxicity earlier. 
 If convulsions occur barbiturates or benzodiazepines can be given. 
 Succinylcholine  1 mg / kg to paralyse the patient and aids in 
controlling the seizures. 
 Cardiac toxicity like fibrillation can be treated by defibrillation 
 Ventilatory support – 100 % oxygenation, intubation etc., 
 Maintain B.P. by rapid infusion of I.V. fluids, use of vasopressors 
and put the patient in Trendelenberg’s position. 
 Maintain fluid and electrolyte balance. 
Adverse effects : 
1. Allergic and hypersensitivity reactions 
  Due to the preservative used – methylparaben 
2. CVS : 




REVIEW OF LITERATURE 
 
1. Pierre Pandin and Nathalie Vancutsem et al conducted a 
random study in which 119 ASA I and II patients scheduled for surgery 
below the knee were taken. Needle was advanced similar to the anterior 
approach of sciatic nerve. Thirty and 15 mL of 0.5% ropivacaine were 
injected close to the femoral and the SCN, respectively. Landmarks were 
determined within 1.7 min. The entire procedure was performed within 
4.2 min. from the determination of the landmark to the SCN infiltration. 
The three-in-one technique was successful in 89.9% while SCN was 
successful in 94.9%. Femoral and tibial nerves were always blocked. 
Blockade of the posterior cutaneous femoral nerve was observed in 78% 
of patients. The extent and the quality of the sensory block always 
allowed surgery. Additional IV sedation was needed in 32.6% of patients. 
Motor block (adapted Bromage’s scale > 2) was observed in the femoral 
(98.3%), the obturator (84.8%), the tibial (97.4%) and the common 
peroneal (85.7%) nerve distributions.  
 
2. Steur, R.J.and Blajenovde Lange et al studied the injection 
point for the combined Sciatic-Femoral nerve block is as for the sciatic 
block described by Berdt in the anterior approach in 22 children. This 
needle entry point is marked on the pre-operative visit; an EMLA-patchˆ 
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is applied on the ward 1 hour before the block. With a current of 0.8 
mAmp at 2 Hz motor contractions of the Quadriceps muscle femoral 
nerve is blocked then the needle pulled back to the subcutis and redirect 
to the Sciatic nerve. The needle is advanced perpendicular to the skin, 
medial of the Femur until twitches in the foot will been seen, indicating a 
stimulation of the Sciatic nerve. Above a threshold of 0.2 mAmp.By the 
one injection technique for both the femoral and sciatic nerve block, as 
described, both nerves were reached in 22 patients from anterior and this 
approach is well accepted by the children and their parents. 
 
3. Chelly JE, Delaunay L.Department of Anesthesiology, The 
University of Texas conducted a comparative study in which  Sciatic 
nerve blocks were performed in 22 patients with varying concentration of 
mepivacaine. Appropriate landmarks were determined within 1.3 min 
(0.5-2.0 min). The sciatic nerve was identified in all patients within 2.5 
min (1.2-5 min), starting from the beginning of the appropriate landmark 
determination to the stimulation of its common peroneal nerve 
component in 13 cases and its tibial nerve component in 9 cases. A 
complete sensory block in the distribution of both the common peroneal 
nerve component and the tibial nerve component was obtained within 15 
min (5-30 min). A shorter onset was observed in patients who received 
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mepivacaine alone compared with those who received a mixture of 
mepivacaine plus ropivacaine (10 min [5-25 min] vs. 20 min [10-30 min]; 
P < 0.05). Recovery time was 4.6 h (2.5-5.5 h) after mepivacaine 
administration. The addition of ropivacaine produced a block of a much 
longer duration 13.8 h (5.2-23.6 h); P < 0.05. No complications were 
observed  
 
4. Alain C. Van Elstraete and Claude Poey et al, conducted a 
study assessed the reliability of the inguinal crease and femoral artery as 
anatomic landmarks for the anterior approach to the sciatic nerve and 
determined the optimal position of the leg during this approach. The 
sciatic nerve was located twice in 20 patients undergoing ankle or foot 
surgery, once with the leg in the neutral position and once with the leg in 
the externally rotated position. The patient was lying supine. A 22-gauge, 
150-mm insulated b-beveled needle connected to a nerve stimulator was 
inserted 2.5 cm distal to the inguinal crease and 2.5 cm medial to the 
femoral artery and was directed posteriorly and laterally with a 10°–15° 
angle relative to the vertical plane. The sciatic nerve was located in all 
patients at a depth of 10.6 ± 1.8 cm when the leg was in the neutral 
position and 10.4 ± 1.5 cm when the leg was in the externally rotated 
position . In the neutral position and in the externally rotated position, the 
time needed to identify anatomic landmarks was 28 ± 15 s and 26 ± 14 s, 
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respectively  and the time needed to locate the sciatic nerve was 79 ± 53 s 
and 46 ± 25 s (P < 0.006), respectively. We conclude that the inguinal 
crease and femoral artery are reliable and effective anatomic landmarks 
for the anterior approach to the sciatic nerve and that the optimal position 
of the leg is the externally rotated position. This new anterior approach to 
the sciatic nerve using the inguinal crease and femoral artery as 
landmarks is an easy and reliable technique.  
5.Jerry D. Vloka and Admir conducted a study in 22 patients to 
know the effects of leg rotation to locate the sciatic nerve in the anterior 
approach to the sciatic nerve block, the femur often obstructs the passage 
of the needle toward the sciatic nerve. Needles were used to stimulate the 
anterior approach to the sciatic nerve block. The effect of leg rotation on 
the needle plane required to reach the sciatic nerve was studied with legs 
in the neutral position and then with internal and external rotation (45°) of 
the legs. During needle placement in the neutral position, the needle could 
not be fully advanced to the level of the sciatic nerve because of 
obstruction by the lesser trichinae in 80% of attempts. Medial redirection 
of the needle (10°–15°) allowed it to pass the lesser trichinae but brought 
the tip of the needle too medial to the sciatic nerve. Internal rotation of the 
leg facilitated passage of all needles inserted at the level of the lesser 
trochanter.This study conclude that internal rotation of the leg may 
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significantly facilitate needle insertion in the anterior approach to sciatic 
block.  
 
6. Fuzier R, Albert N et al. conducted a comparative study 
between anterior approach and lateral approach with the patient in the 
supine position. In emergency setting. 59 patients undergoing post-
traumatic lower extremity surgery under a sciatic nerve block were 
randomly assigned to a lateral or an anterior approach. After appropriate 
positioning ,with150-mm insulated needle using a nerve stimulator sciatic 
nerve was located, 25 ml of ropivacaine 0.75% were injected. Time to 
perform the block, sciatic nerve depth, success rate, and patient's comfort 
were analyzed. The mean time to perform the block was 4.9+/-4.0 min in 
the anterior group and 6.1+/-6.9 min in the lateral group (NS). The mean 
depth of sciatic nerve localization was 107+/-17 mm in the anterior group 
and 91+/-20 mm in the lateral group (P<0.05). Although the success was 
similar in both group (77% in the anterior group vs. 79% in the lateral 
group), the number of technical failure (sciatic nerve stimulation 
impossible) was higher with the anterior approach (86% vs. 33%; 




7.Raghu S. Thota, Ajay Aravind et al conducted imaging 
techniques for identifying the sciatic nerve. Using an anterior approach to 
the sciatic nerve ,sciatic nerve blockade was done, who presented with 
calcaneal fractures requiring open reduction and internal fixation. The 
presence of severe back spasms precluded positioning for a posterior 
approach to the sciatic nerve. Using a C-arm fluoroscopy unit the lesser 
trochanter of the femur was identified using a 15-cm 22-guage spinal 
needle. A small amount of nonionic contrast medium (Omnipaque) 
confirmed needle placement before injecting 20 mL of 0.25% bupivicaine 
. This anterior approach to the sciatic nerve when combined with 
fluoroscopy and contrast media injection is an acceptable anaesthetic 
technique for repair of calcaneal fractures when general anesthesia is to 
be avoided.  
 
 
8.Marty L. Ericksen Jeffrey D. showed anatomic relationship of 
the sciatic nerve to the lesser trochanter, which was analyzed  by 
magnetic resonance scans performed on 20 patients in the supine position. 
Images from five axial levels were studied, specifically, at the level of the 
lesser trochanter and at 1-cm intervals inferior to the lesser trochanter for 
4 cm. At the level of the lesser trochanter, the sciatic nerve was lateral to 
the femoral border (inaccessible) in 13 of 20 patients with a mean 
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distance of -4.0 ± 7.7 mm. At 4 cm below the lesser trochanter, the sciatic 
nerve was medial to the femoral border (accessible) in 19 of 20 patients 
with a mean distance 7.8 ± 5.8 mm. The distance from the anterior border 
of the femur to the sciatic nerve was 42.9 ± 5.8 mm at the level of the 
lesser trochanter and 45.7 ± 9.5 mm at 4 cm below the lesser trochanter. 
The classic description of the anterior approach to the sciatic nerve 
suggests that the needle be walked off medially at the level of the lesser 
trochanter. In contrast, at 4 cm below the lesser trichinae, the sciatic nerve 
was medial to the femur in 19 of 20 subjects and conclude that needle 
insertion medial to the proximal femur, 4 cm below the lesser trochanter, 







MATERIALS AND METHODS 
Study design: 
 This is a cohort study. This study was conducted at government 
Rajaji Hospital attached to Madurai medical college, Madurai.  
 
40 patients of ASA I – IV physical status who got admitted in ward 
for below knee surgical procedures were taken into consideration.  
 
PROCEDURE 
 After ethical committee approval, and after preoperative evaluation 
and discussion of anesthetic options informed consent was obtained from 
the patients. Intravenous access was obtained. Anaesthesia machine 
checked resuscitative equipments and drugs were kept ready. 
 
Inclusion criteria: 
Age >14 yrs 
Both sexes 
ASA I-IV undergoing surgery for both elective/emergency below knee  
Exclusion criteria 
Age < 14 yrs 
Pregnancy 
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Infection at the puncture site 
Allergy to amide local anaesthetics 
Standard monitoring-BP/pulse/SpO2 
Sterile towels and 4*4 gauge packs 
20ml syringe with local anaesthetics 
Sterile gloves, marking pens, and surface electrodes 
One 25G needle for skin infiltration 
A 15cm long bevel, insulated nerve stimulating needle 
Peripheral nerve stimulator 
 
Procedure: 
Drugs: 20 ml of 2% Lidocaine  with 5 microgram of adrenaline/ml 
  20 ml of 5% bupivacaine  used for the study. Equipments are kept 
ready. After establishing an Intravenous line, patient was positioned 
supine as necessary for combined sciatic and femoral block. 
 
Anatomical Land marks:     
With the patient in supine position 
a) 1st a line drawn connecting the anterior superior iliac spine and 
pubic tubercle  
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b) 2nd line drawn parallel to the 1st line passing along the greater 
trichinae. 
c) The 1st line is divided into three equal parts. From the junction of 
lateral 2/3rd and medial 1/3rd a perpendicular line drawn. The point 
of intersection with the 2nd line is the site of needle entry.     
Under strict aseptic precautions local anesthetics solution was 
prepared and all the equipments, needed like nerve stimulator, insulated 
needle, syringe were kept ready. 
 
First the femoral nerve was blocked using the nerve stimulator .the 
needle was advanced carefully from point C, 45° cephalad and 10° 
medially, to a point until movement of the patella related to the femoral 
nerve stimulation (5–6 cm depth) was observed. The needle was never 
advanced more than 8 cm during this phase. Nerve stimulator output was 
decreased to 0.4 mA to optimize needle placement .initially 3mA current 
was used first to identify the nerve and then gradually reduced to 0.4mA 
till the response is present by moving the needle anterior to posterior, 
then lateral to medial. The patella dance was considered as the evoked 
motor response or end point of nerve location. When the response is 
present at 0.4mA 15ml of the mixture of local anaesthetic solution 
injected after negative aspiration. Immediately the disappearance of the 
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patella dance was noted and gradually strength of the current increased. If 
no response seen it indicators the exact location of the nerve. 
 
The sciatic nerve block was performed after the blockade of the 
femoral nerve with the same point of needle entry, the needle was 
withdrawn to the subcutaneous tissue and redirected 10° laterally and 80° 
caudad.  
 
Initially 3mA Strength was used to first identify the nerve. Within 
a depth of 9.5–13 cm, the sciatic nerve was identified with the evoked 
motor response related to the sciatic nerve –plantar flexion or foot 
inversion is noted. Stimulation of its common peroneal nerve component 
(dorsiflexion or eversion of the foot) or its tibial nerve component 
(plantar flexion and inversion of the foot and flexion of the toes). And 
gradually reduced to 0.4mA till the foot eversion (or) plantar flexion 
movement noticed by moving the needle anterior to posterior and then 
lateral to medial. When the plantar movement is present with 0.4mA 
25ml of the prepared local anaesthetic solution was injected after careful 
aspiration. The intensity of the sensory and motor block was assessed 
every 5 min up to 20 min after being performed and every hour after 
surgery until sensory function recovered in either the common peroneal 
or tibial territory to determine the recovery time. Preoperatively and 
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postoperatively, a three-level scale was used to evaluate the intensity of 
the sensory and motor block (no block, partial and complete block). The 
sensory block was assessed by application of ice to the dorsal aspect of 
the foot (common peroneal nerve) and to the plantar aspect of the foot 
(tibial nerve). The sensory block was considered complete if the patient 
did not feel the cold. Patients were asked to perform a dorsi and plantar 
flexion to assess the intensity of the motor block (normal motor function, 
partial block, and complete block). The motor block was considered 
complete when a motor block was observed in both the common peroneal 
and the tibial territories. The duration of the sensory and motor block was 
defined as the time between the performance of the block and the 
recovery of sensory and any motor function, respectively. 
 
 After confirming the block that has taken up well surgery was 
allowed to proceed. The VAS score was assessed every 1 hr after 
performance of the block. When the VAS score reaches 5, it was taken as 
the duration of pain relief, following which oral analgesic (or) parental 
analgesic was allowed to start. 
 
 Complications such as vascular injury, toxicity of the drug and 
infection were taken into consideration. 
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PARAMETERS OBSERVED  
1. Mean time to perform block- (from the time of skin disinfection to 
the end of injection. 
 
2. Successful block- defined as analgesia in the dermatomal supply of 
sciatic and femoral nerve 
 
3. Onset of Analgesia-Onset of analgesia was taken as abolition of touch 
sensation over the distribution of sciatic and femoral nerve and was 
assessed every minute after the performance of the block. 
 
4. Onset of motor blockade: 
 Onset of motor blockade was assessed every 2 minute after the 
block using three point scale 
 
5.   Duration of analgesia  
 The pain was assessed using visual Analogue scale having 10cm 
length numbered from 0 to 10. Patient was explained about the visual 
Analogue scale as 0 - No pain and 10 the worst possible pain and was 
asked the score in visual analogue scale. 
 The patient was observed every 30 minutes after the surgery is over 
till the motor block reverses and thereafter hourly for 6 hrs .The first VAS 
score to appear  
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Time of which VAS score is greater than 5 is noted and patient was 
given intramuscular NSAID. 
Duration of post operative analgesia ( the period of time after the 
surgery till the patient needs analgesic -VAS score more than 5) 
 
6. Vital parameters 
   Pulse rate 
   Blood pressure 
   Respiratory rate monitored periodically   
    oxygen saturation 
7. Complications: 




OBSERVATION AND RESULTS 
 
Table 1: Age distribution 
 
   
Age group Cases 
No. % 
Up to 20  years 2 5 
21-30 years 2 5 
31-40  years 5 12.3 
41-50 years 10 25 
51-60 years 11 27.5 
61-70 years 6 15 
Above 70 years 4 10 







                                     
 The study was done with the patients aged ranging from 18 years 
as the minimum and 75 years as the maximum age old. The mean age of 
distribution is around 51 years.  




 Out of 40 cases 36 were male and 4 cases were female. 
 Male   - 90% 






Male 36 90 
Female 4 10 
 
 
ASA Class Distribution: 
 Out of 40 cases ASA I include 11 cases; ASA II includes 24 cases; 
ASA III includes 5 cases. 
 ASA I - 27.5% 
 ASA II - 60% 





I 11 27.5 
II 24 60 




 BK amputation    26 cases 65% 
 wound debridement  10 cases 25% 
 SSG     2 cases 5% 
 Flap cover    1 case  2.5% 
 Through ankle disarticulation  1 case  2.5%   
PROCEDURE  Frequency Percent 
BK Amputation  26 65.0 
Flap cover  1 2.5 
SSG  2 5.0 
Through Ankle disarticulation  1 2.5 
Wound debridement  10 25.0 
Total  40 100.0 
 
Femoral Nerve Block: 
 The average onset time of sensory block to temperature is 3.79 
minutes and the range varied from 3minute-6minute. 
 
 The average onset time of sensory block to pin prick is 6.42minute. 
The range varied from 5-8 minute. 
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 Out of the 40 cases 38 cases the sensory blockade was taken well. 





Temp. Pin prick 
No. % No. % 
3 16 42.1 - - 
4 15 39.5 - - 
5 6 15.8 9 23.7 
6 1 2.6 9 23.7 
7 - - 15 39.5 
8 - - 5 13.2 












Sciatic Nerve Block: 
 The average onset time for sensory block to temperature is 
6.62minute. The range varied from 5-9 minute. The average onset time 
for sensory block to principle is 10.24minute. The range varied from 7-13 
minute. 
 
 Out of the 40 cases, 37 cases the sensory blockade was well taken 
up. In 3 cases it was spared. 
 
 The average percentage for motor block to sciatic nerve was 48%. 
It include  
Complete motor blockade      - 67.5% 
Partial motor blockade  - 17.5% 
No motor blockade  - 15% 
 
Out of the 40 blocks that were performed, 35 cases had taken up 
well, 2 blocks had failed because of failed femoral blockade and 3 were 










Onset time – Sciatic 
(in minutes) 
Temp. Pin prick 
No. % No. % 
5 6 16.2 - - 
6 13 35.1 - - 
7 11 29.7 1 2.7 
8 3 8.1 4 10.8 
9 4 10.8 10 27 
10 - - 8 21.6 
11 - - 5 13.5 
12 - - 2 5.4 
13 - - 7 18.9 













Motor Block  
 
Motor Block Score 
Cases 
No. % 
0 27 67.5 
1 7 17.5 
2 6 15 








Block was considered failed, if no pain relief to pinprick even after 
30 min after the performance of the block. 
The success rate of the femoral block was – 95% (38 cases) 









Femoral 2 5 
Sciatic 3 7.5 
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Time for procedure: 
   




Up to 15 10 25 
16-20 18 45 
21-25 12 30 
Above 25 - - 









The average time that is required for the performance of the block 
was around – 18.23 minutes. The time varied from 3minute – 25 minute. 
 
Post operative analgesia: 
 The average time that post operative pain relief after the surgery 
was around 263.5minute. The time ranged from 210-330 minutes.    
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Post Operative Analgesia  
 
   
Post Operative Analgesia
 (in minutes) 
Cases 
No. % 
0-180 - - 
181-210 3 7.5 
211-240 12 30 
241-270 17 42.5 
271-300 6 15 
300-330 2 5 

















In my study a regional technique- sciatic and femoral nerve were 
blocked through anterior approach using peripheral nerve stimulator for 
below knee surgeries. It is safe, not threatening or unpleasant to the 
patient, allows adequate surgical access to the operative site, and causes 
as little disturbance as possible to the internal homeostatic mechanisms. 
The sciatic nerve can be approached with the patient either supine or in 
the Sims position. In my study sciatic and femoral nerve block was 
performed with patient in supine position and also it is performed via 
single point of entry. 
  The land marks were drawn on an average of 1.8 minutes. The 
average time to perform the block was 18.23 + 3.19 minutes. The success 
of femoral nerve block was 95% and sciatic was 92.5%.  Jerry D. Vloka 
et al  studied the success rate of locating the sciatic nerve was improved 
by inward rotating the leg(5)  and locate the  nerve in 80% of the 
individual in first attempt there by improving the success rate. 
Redirecting the needle 10-15 medially along the lesser troachanter 
increased to locate the sciatic nerve(4). 
The success rate of combined sciatic and femoral block in my 
study was 92.5% and 95%. This is similar to that of the study conducted 
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by Pierre Pandin et al in 119 patients(1). In his study femoral nerve was 
blocked in 90% and sciatic nerve was blocked in 95% 
Fuzier R, et al conducted a comparative study in 60 patients in 
emergency lower limb surgeries. He concluded that the success rate of 
both the anterior (80%) and lateral approach (85%) of the sciatic nerve 
blockade the same(6).  
This is similar to that of the success rate 92.5% in my study. 
In this study the duration of postoperative analgesia lasted for  
263.5 minutes which is similar to that of the duration produced by 
mepivacaine which is around 270 hours. 
This is the only alternative technique to neuraxial blockade in 
which this technique absolute or relative contraindications. 
The technique has substantial advantages, such as easy landmark, 
low risk of vascular injury and impossibility of complications such as 
total spinal or epidural Anesthesia. This technique allows the patient to be 
placed in supine position which over comes the disadvantage of shifting 
and positioning in trauma patients. This technique can be used in patients 
on oral anti coagulants and with reduced cardio pulmonary reserve. 
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SUMMARY 
 40 patients admitted in ward planed for below the surgeries were 
given combined sciatic and fermoral nerve block through anterior 
approach via single point of entry. Nerve stimulator was used for the 
block using evoked motor response as the end point for performance of 
the block. This block produces a success rate of 90%. It produced 
adequate level of surgical anaesthesia, better hemodynamic stability. It 
also provides substantial post operative pain relief for these patients.  
















This easy and reliable anterior technique for performing sciatic and 
femoral nerve blocks is an alternative to subarachnoid block for below 
knee surgeries although it is not a substitution and it is suitable especially 
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1 Ayyanar 58 M 23932 II Cellulitis leg BK Amputation 4 8 7 13 0 22  255 2 
2 Sonai 46 M 25375 I ulcer foot Wound debridement 3 5 6 9 0 15  270 2 
3 Ponnuthai 48 F 41124 II Ch.ulcer Leg BK Amputation 4 7 7 10 0 21  240 2 
4 Vellusamy 60 M 46473 II D.M. Foot 
Through Ankle 
disarticulation  
3 5 6 9 0 16  270 2 
5 Mariappan 72 M 48483 II Crush injury foot BK Amputation 4 7 6 9 1 15  300 2 
6 Cellaiya 70 M 24538 III Disease leg  BK Amputation 4 8 6 12 0 17  330 2 
7 Ajmalkhan 51 M 24452 III Cellulitis leg Wound debridement 5 8 9 13 0 19  240 2 
8 Ramesh kumar 18 M 23023 I Crush injury foot BK Amputation 3 6 6 9 0 13  315 2 
9 Karuppiah 60 M 31568 II gangrene foot BK Amputation 5 8 5 7 2 18  240 2 




60 M 54177 II Cellulitis leg BK Amputation 6 8 9 13 0 21  240 2 
12 Kasthuri 60 F 47242 II D.M. Foot BK Amputation 5 7 9 13 0 20  300 2 
13 Ramesh 47 M 43766 II D.M. Foot BK Amputation 3 6 8 13 2 17  240 2 
14 Annamalai 65 M 2942 II gangrene foot BK Amputation   8 11 0 22 Femoral 225 2 
15 Murugan 50 M 16313 I ulcer foot Flap cover 4 6 6 10 0 18  270 2 

































































































































































52 M 21123 II D.M ulcer foot Wound debridement 3 6 5 8 0 16  240 2 
18 Anbu 42 M 90344 II #BB Leg Septicemia BK Amputation 3 6 7 12 1 22  270 2 
19 Asha 40 F 49836 II D.M. Foot BK Amputation 4 7 9 13 2 19  270 2 
20 Idumban 64 M 10031 II Cellulitis leg BK Amputation 4 6 7 10 0 15  270 2 
21 Anbarasan 20 M 98010 I #BB Leg  Wound debridement 4 7 5 9 0 17  270 2 
22 Murugan 33 M 6624 II TAO non h.ulcer BK Amputation 4 6 7 10 0 17  210 2 
23 Gopal 44 M 1677 II Cellulitis leg BK Amputation 4 7 7 11 0 25  270 2 
24 Pandi 34 M 97586 I Non H.Ulcer leg Wound debridement 4 7 7 11 1 15  255 2 
25 Chinnaiyan 62 M 97561 II Gangrene Leg BK Amputation 4 7 8 13 0 20  285 2 
26 Kalimuthu 40 M 16669 II TAO non h.ulcer BK Amputation 4 7 7 11 1 20  270 2 
27 Kaliappan 34 M 10049 I Crush injury foot Wound debridement 4 7 6 10 0 21  255 2 
28 Chandran 44 M 11316 II Gangrene Leg BK Amputation 5 7   2 23 Sciatic  2 
29 Velusamy 66 M 88396 II Gangrene Leg BK Amputation 3 5 6 9 0 15  270 2 
30 Pandi 62 M 22098 I Ch.ulcer Leg Wound debridement   7 10 0 22 Femoral 300 2 
31 Velu 60 M 23395 II D.M. Foot BK Amputation 3 5 5 8 0 18  300 2 
32 Durairajan 55 M 51422 II D.M. Foot BK Amputation 5 7   2 20 Sciatic  2 
33 Ganesan 75 M 29003 III 
Aorto occulisive 
disease leg 
BK Amputation 3 7 6 9 1 22  240 2 






























































































































































35 Dhanalakshmi 71 M 20575 III TAO Leg gangrerne BK Amputation 3 5 5 8 0 13  270 2 
36 Anandha kumar 26 M 22316 II Crush injury foot Wound debridement 3 5 7 9 0 16  270 2 
37 Thangavel 45 M 37344 II Gangrene Leg BK Amputation 3 5   2 21 Sciatic  2 
38 Gnanakan 75 M 24462 III TAO Leg gangrerne BK Amputation 3 5 6 10 1 16  210 2 
39 Kalimuthu 45 M 37544 I in jury Foot Wound debridement 3 6 5 8 0 13  270 2 
































































































ONSET TIME - SCIATIC 
6.62
10.24










































































POST OPERATIVE ANALGESIA 
181-210 
minutes
8%
211-240 
minutes
30%
241-270 
minutes
42%
271-300 
minutes
15%
301-330 
minutes
5%
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